Philip Aschi, DO, Urology Associates of Southwest Ohio, has been designated a 2022 UroLift® Center of Excellence by achieving a higher level of training with the UroLift® System and by demonstrating a commitment to care for men suffering from symptoms associated with enlarged prostates, known as benign prostatic hyperplasia (BPH).
The UroLift® System is a minimally invasive treatment that fills the gap between prescription medications and more invasive surgical procedures to treat BPH.
“UroLift® is a great advance in technology to bridge the gap between lifelong medicine, versus invasive surgeries. It has the best safety profile of any BPH procedure and excellent data on five-year durability,’’ said Philip Aschi, DO, Urology Associates of Southwest Ohio.
Treatment with the UroLift® System is typically a one-time, in-office solution that provides rapid relief and recovery of BPH symptoms. It can break the cycle of medications and how they make a person feel, all without the risks of more invasive surgery. The goal of the UroLift System treatment is to relieve symptoms so patients can get back to their lives and resume daily activities.
The UroLift System treatment has demonstrated a significant improvement in the quality of life for patients compared to medications. The UroLift System is the only BPH procedure shown not to cause new and lasting erectile or ejaculatory dysfunction while being a safe and effective treatment of lower urinary tract symptoms due to BPH.
To learn more about the UroLift System or to schedule an appointment with Dr. Aschi, call 937.283.2560.